Pharma Management Consulting Denmark ApS: Financial statements 2025
CVR: 44364182
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharma Management Consulting Denmark ApS (CVR 44364182) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,297,872 and a net result of DKK 196,191. Equity in the 2025 report amounted to DKK 243,069. The solvency ratio was 53.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,297,872
- Profit/Loss
- DKK 196,191
- Equity
- DKK 243,069
- Total Assets
- DKK 453,615
- Employees
- 1
Official annual report
How creditworthy is Pharma Management Consulting Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharma Management Consulting Denmark ApS has published its interim report for the period October 11, 2023 to December 31, 2024.
About Pharma Management Consulting Denmark ApS
Pharma Management Consulting Denmark ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2023. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of David Jung Thelander Grønbæk. The company is owned by North Star Business Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,297,872 and a net result of DKK 196,191. Equity in the 2025 report amounted to DKK 243,069.